Cost‐effectiveness of screening and valacyclovir‐based treatment strategies for first‐trimester cytomegalovirus primary infection in pregnant women in France von Périllaud‐Dubois, C., Hachicha‐Maalej, N., Lepers, C., Letamendia, E., Teissier, N., Cousien, A., Sibiude, J., Deuffic‐Burban, S., Vauloup‐Fellous, C., Picone, O.

Volltext

Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France von Cousien, A., Tran, V. C., Deuffic‐Burban, S., Jauffret‐Roustide, M., Mabileau, G., Dhersin, J.‐S., Yazdanpanah, Y.

Volltext

Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case von Deuffic-Burban, S., Obach, D., Canva, V., Pol, S., Roudot-Thoraval, F., Dhumeaux, D., Mathurin, P., Yazdanpanah, Y.

Volltext

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States von Deuffic-Burban, S., Poynard, T., Sulkowski, M. S., Wong, J. B.

Volltext

Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review von Cousien, A., Tran, V. C., Deuffic-Burban, S., Jauffret-Roustide, M., Dhersin, J.-S., Yazdanpanah, Y.

Volltext

The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference von Hatzakis, A., Van Damme, P., Alcorn, K., Gore, C., Benazzouz, M., Berkane, S., Buti, M., Carballo, M., Cortes Martins, H., Deuffic-Burban, S., Dominguez, A., Donoghoe, M., Elzouki, A-N., Ben-Alaya Bouafif, N., Esmat, G., Esteban, R., Fabri, M., Fenton, K., Goldberg, D., Goulis, I., Hadjichristodoulou, T., Hatzigeorgiou, T., Hamouda, O., Hasurdjiev, S., Hughes, S., Kautz, A., Malik, M., Manolakopoulos, S., Matičič, M., Papatheodoridis, G., Peck, R., Peterle, A., Potamitis, G., Prati, D., Roudot-Thoraval, F., Reic, T., Sharara, A., Shennak, M., Shiha, G., Shouval, D., Sočan, M., Thomas, H., Thursz, M., Tosti, M., Trépo, C., Vince, A., Vounou, E., Wiessing, L., Manns, M.

Volltext

Efficacy of new antiretroviral drugs in treatment‐experienced HIV‐infected patients: a systematic review and meta‐analysis of recent randomized controlled trials von Pichenot, M, Deuffic‐Burban, S, Cuzin, L, Yazdanpanah, Y

Volltext

Risk Factors for Hepatitis C Virus Transmission to Health Care Workers after Occupational Exposure: A European Case-Control Study von Yazdanpanah, Y., De Carli, G., Migueres, B., Lot, F., Campins, M., Colombo, C., Thomas, T., Deuffic-Burban, S., Prevot, M. H., Domart, M., Tarantola, A., Abiteboul, D., Deny, P., Pol, S., Desenclos, J. C., Puro, V., Bouvet, E.

Volltext

Blood-borne viruses in health care workers: Prevention and management von Deuffic-Burban, S, Delarocque-Astagneau, E, Abiteboul, D, Bouvet, E, Yazdanpanah, Y

Volltext

Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit... von Sanna, Alice, Le Strat, Yann, Roudot-Thoraval, Françoise, Deuffic Burban, Sylvie, Carrieri, Patrizia, Delarocque-Astagneau, Elisabeth, Larsen, Christine

Volltext

Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model von Deuffic-Burban, S., Poynard, T., Valleron, A.-J.

Volltext

Cost-effectiveness of QuantiFERON®-TB test vs. tuberculin skin test in the diagnosis of latent tuberculosis infection von DEUFFIC-BURBAN, S, ATSOU, K, VIGET, N, MELLIEZ, H, BOUVET, E, YAZDANPANAH, Y

Volltext

O017 : Effectiveness of treatment initiation based on fibrosis stage assessed by methods of fibrosis diagnosis in terms of 5-year incidence of morbi-mortality von Deuffic-Burban, S, Boursier, J, Leroy, V, Castera, L, Mathurin, P

Volltext

Cost-Effectiveness and Budget Impact of Interferon-Free Direct-Acting Antiviral (DAA)-Based Regimens for Chronic Hepatitis C Treatment. The French Case von Deuffic-Burban, S, Obach, D, Canva, V, Pol, S, Roudot-Thoraval, F, Dhumeaux, D, Mathurin, P, Yazdanpanah, Y

Volltext

Effectiveness and cost-effectiveness of antiviral treatment initiation in hepatitis C related decompensated cirrhosis in France von Willmington, C, Ganne-Carrié, N, Roudot-Thoraval, F, Leroy, V, Fontaine, H, Canva-Delcambre, V, Larrey, D, Pol, S, Mathurin, P, Yazdanpanah, Y, Deuffic-Burban, S

Volltext

Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections von Deuffic-Burban, Sylvie, Mohamed, Mostafa K., Larouze, Bernard, Carrat, Fabrice, Valleron, Alain-Jacques

Volltext

Clinical and Social Psychological Profiles of Patients with Chronic Hepatitis C Treated with IFN-Free Regimens in France von Cossais, S, Schwarzinger, M, Pol, S, Fontaine, H, Larrey, D, Pageaux, G.-P, Canva, V, Mathurin, P, Yazdanpanah, Y, Deuffic- Burban, S

Volltext

O89 IMPACT OF NEW DAA-CONTAINING REGIMENS ON HCV TRANSMISSION AMONG INJECTING DRUG USERS (IDUS): A MODEL-BASED ANALYSIS (ANRS 12376) von Cousien, A, Tran, V.C, Jauffret-Roustide, M, Deuffic-Burban, S, Dhersin, J.-S, Yazdanpanah, Y

Volltext

P0745 : EQ-5D utility index in French patients with chronic hepatits C (CHC) infection: severe comorbidities and perceived progression of CHC infection matter more than actual live... von Schwarzinger, M, Cossais, S, Deuffic-Burban, S, Pol, S, Fontaine, H, Larrey, D, Pageaux, G.-P, Canva, V, Mathurin, P, Yazdanpanah, Y

Volltext

O85 SHOULD WE AWAIT INTERFERON-FREE REGIMENS TO TREAT HCV GENOTYPE 1 TREATMENT-NAIVE PATIENTS? A COST-EFFECTIVENESS ANALYSIS (ANRS 12188) von Deuffic-Burban, S, Schwarzinger, M, Obach, D, Mallet, V, Pol, S, Pageaux, G.-P, Canva, V, Deltenre, P, Roudot-Thoraval, F, Larrey, D, Dhumeaux, D, Mathurin, P, Yazdanpanah, Y

Volltext